187 related articles for article (PubMed ID: 30130730)
1. CXCL9 promotes the progression of diffuse large B-cell lymphoma through up-regulating β-catenin.
Ruiduo C; Ying D; Qiwei W
Biomed Pharmacother; 2018 Nov; 107():689-695. PubMed ID: 30130730
[TBL] [Abstract][Full Text] [Related]
2. Metadherin contributes to the pathogenesis of diffuse large B-cell lymphoma.
Ge X; Lv X; Feng L; Liu X; Gao J; Chen N; Wang X
PLoS One; 2012; 7(6):e39449. PubMed ID: 22768080
[TBL] [Abstract][Full Text] [Related]
3. FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway.
Meng H; Zhao B; Wang Y
Exp Mol Pathol; 2020 Aug; 115():104451. PubMed ID: 32417392
[TBL] [Abstract][Full Text] [Related]
4. GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway.
Wang Z; Ran X; Qian S; Hou H; Dong M; Wu S; Ding M; Zhang Y; Zhang X; Zhang M; Chen Q
Arch Biochem Biophys; 2021 Oct; 710():108998. PubMed ID: 34280359
[TBL] [Abstract][Full Text] [Related]
5. LncRNA FIRRE is activated by MYC and promotes the development of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway.
Shi X; Cui Z; Liu X; Wu S; Wu Y; Fang F; Zhao H
Biochem Biophys Res Commun; 2019 Mar; 510(4):594-600. PubMed ID: 30739786
[TBL] [Abstract][Full Text] [Related]
6. High expression and nuclear localization of β-catenin in diffuse large B-cell lymphoma.
Ge X; Lv X; Feng L; Liu X; Wang X
Mol Med Rep; 2012 Jun; 5(6):1433-7. PubMed ID: 22427053
[TBL] [Abstract][Full Text] [Related]
7. G protein nucleolar 3 promotes Non-Hodgkin lymphoma progression by activating the Wnt/β-catenin signaling pathway.
Dai R; Wu M; Zhang Y; Zhu Z; Shi J
Exp Cell Res; 2021 Dec; 409(2):112911. PubMed ID: 34762898
[TBL] [Abstract][Full Text] [Related]
8. Aberrant NEAT1_1 expression may be a predictive marker of poor prognosis in diffuse large B cell lymphoma.
Deng L; Jiang L; Tseng KF; Liu Y; Zhang X; Dong R; Lu Z; Wang X
Cancer Biomark; 2018; 23(2):157-164. PubMed ID: 30175971
[TBL] [Abstract][Full Text] [Related]
9. TIMD4 exhibits regulatory capability on the proliferation and apoptosis of diffuse large B-cell lymphoma cells via the Wnt/β-catenin pathway.
Li Y; Zhang PY; Yang ZW; Ma F; Li FX
J Gene Med; 2020 Aug; 22(8):e3186. PubMed ID: 32187802
[TBL] [Abstract][Full Text] [Related]
10. CXC chemokine ligand 16, inversely correlated with CD99 expression in Hodgkin Reed-Sternberg cells, is widely expressed in diverse types of lymphomas.
Liu F; Zhang Y; Tang H; Zhou X; Wu Z; Tang D; Zhao T
Oncol Rep; 2013 Aug; 30(2):783-92. PubMed ID: 23743627
[TBL] [Abstract][Full Text] [Related]
11. HOXD3 Up-regulating KDM5C Promotes Malignant Progression of Diffuse Large B-Cell Lymphoma by Decreasing p53 Expression.
Cui Y; Lv C; Wen Y; Zhao D; Yang Y; Qiu H; Wang C
Balkan Med J; 2022 Jan; 39(1):30-38. PubMed ID: 34928233
[TBL] [Abstract][Full Text] [Related]
12. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
13. Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis.
Ejaeidi AA; Craft BS; Puneky LV; Lewis RE; Cruse JM
Exp Mol Pathol; 2015 Aug; 99(1):163-72. PubMed ID: 26079660
[TBL] [Abstract][Full Text] [Related]
14. SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation.
Liu H; Hu J; Wei R; Zhou L; Pan H; Zhu H; Huang M; Luo J; Xu W
J Exp Clin Cancer Res; 2018 Sep; 37(1):229. PubMed ID: 30249289
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.
Zhong W; Xu X; Zhu Z; Du Q; Du H; Yang L; Ling Y; Xiong H; Li Q
Oncotarget; 2017 Jul; 8(30):49757-49772. PubMed ID: 28537908
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas.
Bognar MK; Vincendeau M; Erdmann T; Seeholzer T; Grau M; Linnemann JR; Ruland J; Scheel CH; Lenz P; Ott G; Lenz G; Hauck SM; Krappmann D
Oncogene; 2016 Aug; 35(32):4269-81. PubMed ID: 26776161
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of the expression and significance of CXCLs in human diffuse large B-cell lymphoma.
Zhou X; Guo S; Shi Y
Sci Rep; 2022 Feb; 12(1):2817. PubMed ID: 35181719
[TBL] [Abstract][Full Text] [Related]
18. Astrocyte elevated gene-1 interacts with β-catenin and increases migration and invasion of colorectal carcinoma.
Zhang F; Yang Q; Meng F; Shi H; Li H; Liang Y; Han A
Mol Carcinog; 2013 Aug; 52(8):603-10. PubMed ID: 22431469
[TBL] [Abstract][Full Text] [Related]
19. FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.
Walker MP; Stopford CM; Cederlund M; Fang F; Jahn C; Rabinowitz AD; Goldfarb D; Graham DM; Yan F; Deal AM; Fedoriw Y; Richards KL; Davis IJ; Weidinger G; Damania B; Major MB
Sci Signal; 2015 Feb; 8(362):ra12. PubMed ID: 25650440
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β-catenin-EGFR-PI3K-Akt-mTOR signaling pathway.
Zhang B; Deng C; Wang L; Zhou F; Zhang S; Kang W; Zhan P; Chen J; Shen S; Guo H; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Kong B; Friess H; Zhuge Y; Yan H; Zou X
Mol Carcinog; 2018 Feb; 57(2):201-215. PubMed ID: 29027712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
